Erratum: Genome-wide analysis of the heritability of amyotrophic lateral sclerosis (JAMA Neurology (2014) 71:9 (1123-1133). DOI: 10.1001/jamaneurol.2014.1184);Genome-wide analysis of the heritability of amyotrophic lateral sclerosis

JAMA Neurology

Volumn 71, Issue 9, 2014, Pages 1123-1133

  Keller, Margaux F ^a,b   Ferrucci, Luigi ^a   Singleton, Andrew B ^a   Tienari, Pentti J ^c   Laaksovirta, Hannu ^c   Restagno, Gabriella ^d   Chiò, Adriano ^e   Traynor, Bryan J ^a   Nalls, Michael A ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b TEMPLE UNIVERSITY   (United States)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d ASO OIRM Sant'Anna   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS;

AMYOTROPHIC LATERAL SCLEROSIS; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84907562357     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2014.2914     Document Type: Erratum

References (49)

1. Chiò A, Mora G, Calvo A, Mazzini L, Bottacchi E, Mutani R; PARALS. Epidemiology of ALS in Italy: a 10-year prospective population-based study. Neurology. 2009;72(8):725-731.
2. Johnson L, Miller JW, Gkazi AS, et al. Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients. Neurobiol Aging. 2012;33(12):2948.e15-2948.17.
3. Al-Chalabi A, Fang F, Hanby MF, et al. An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry. 2010;81(12):1324-1326.
4. Chiò A, Logroscino G, Traynor BJ, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41(2):118-130.
5. Fang F, Kamel F, Lichtenstein P, et al. Familial aggregation of amyotrophic lateral sclerosis. Ann Neurol. 2009;66(1):94-99.
6. Renton AE, Majounie E, Waite A, et al ITALSGEN Consortium. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257-268.
7. Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2007;16(R2):R233-R242.
8. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245-256.
9. Chiò A, Schymick JC, Restagno G, et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2009;18(8):1524-1532.
10. Landers JE, Melki J, Meininger V, et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 2009;106(22):9004-9009.
11. Bettens K, Brouwers N, Van Miegroet H, et al. Follow-up study of susceptibility loci for Alzheimer's disease and onset age identified by genome-wide association. J Alzheimers Dis. 2010;19(4):1169-1175.
12. Cronin S, Berger S, Ding J, et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet. 2008;17(5):768-774.
13. van Es MA, Van Vught PW, Blauw HM, et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 2007;6(10):869-877.
14. Laaksovirta H, Peuralinna T, Schymick JC, et al. Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study. Lancet Neurol. 2010;9(10):978-985.
15. Wingo TS, Cutler DJ, Yarab N, Kelly CM, Glass JD. The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS One. 2011;6(11):e27985.
16. Yang J, Benyamin B, McEvoy BP, et al. Common SNPs explain a large proportion of the heritability for human height. Nat Genet. 2010;42(7):565-569.
17. Yang J, Manolio TA, Pasquale LR, et al. Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet. 2011;43(6):519-525.
18. Yang J, Lee SH, Goddard ME, Visscher PM. Genome-wide complex trait analysis (GCTA): methods, data analyses, and interpretations. Methods Mol Biol. 2013;1019:215-236.
19. Fogh I, Ratti A, Gellera C, et al SLAGEN Consortium and Collaborators; ITALSGEN Consortium. A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. Hum Mol Genet. 2014;23(8):2220-2231.
20. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88(1):76-82.
21. Schymick JC, Scholz SW, Fung HC, et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 2007;6(4):322-328.
22. Traynor BJ, Nalls M, Lai SL, et al. Kinesin-associated protein 3 (KIFAP3) has no effect on survival in a population-based cohort of ALS patients. Proc Natl Acad Sci U S A. 2010;107(27):12335-12338.
23. Purcell S, Neale B, Todd-Brown K, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559-575.
24. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38(8):904-909.
25. Germain M, Saut N, Greliche N, et al. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS ONE. 2011;6(9):e25581.
26. Price AL, Zaitlen NA, Reich D, Patterson N. New approaches to population stratification in genome-wide association studies. Nat Rev Genet. 2010;11(7):459-463.
27. de Bakker PIW, Ferreira MAR, Jia X, Neale BM, Raychaudhuri S, Voight BF. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet. 2008;17(R2):R122-R128.
28. Chiò A, Logroscino G, Hardiman O, et al Eurals Consortium. Prognostic factors in ALS: A critical review. Amyotroph Lateral Scler. 2009;10(5-6):310-323.
29. Turner MR, Barnwell J, Al-Chalabi A, Eisen A. Young-onset amyotrophic lateral sclerosis: historical and other observations. Brain. 2012;135(pt 9):2883-2891.
30. Turner MR, Wicks P, Brownstein CA, et al. Concordance between site of onset and limb dominance in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2011;82(8):853-854.
31. Byrne S, Jordan I, Elamin M, Hardiman O. Age at onset of amyotrophic lateral sclerosis is proportional to life expectancy. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14(7-8):604-607.
32. Traynor BJ, Codd MB, Corr B, Forde C, Frost E, Hardiman O. Incidence and prevalence of ALS in Ireland, 1995-1997: a population-based study. Neurology. 1999;52(3):504-509.
33. Mitchell JD, Borasio GD. Amyotrophic lateral sclerosis. Lancet. 2007;369(9578):2031-2041.
34. Piemonte and Valle d'Aosta Register for Amyotrophic Lateral Sclerosis (PARALS). Incidence of ALS in Italy: evidence for a uniform frequency in Western countries. Neurology. 2001;56(2):239-244.
35. Logroscino G, Traynor BJ, Hardiman O, et al EURALS. Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2010;81(4):385-390.
36. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47(2):571-573.
37. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency inmeta-analyses. BMJ. 2003;327(7414):557-560.
38. Johnson JO, Mandrioli J, Benatar M, et al ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010;68(5):857-864.
39. Do CB, Tung JY, Dorfman E, et al. Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease. PLoS Genet. 2011;7(6):e1002141.
40. Zheng JS, Arnett DK, Lee YC, et al. Genome-wide contribution of genotype by environment interaction to variation of diabetes-related traits. PLoS ONE. 2013;8(10):e77442.
41. Calvo A, Moglia C, Canosa A, et al. A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol Aging. 2014;35(6):1513.e7-1513.e11.
42. Kasperaviciute D, Weale ME, Shianna KV, et al. Large-scale pathways-based association study in amyotrophic lateral sclerosis. Brain. 2007;130(pt 9):2292-2301.
43. Shatunov A, Mok K, Newhouse S, et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. Lancet Neurol. 2010;9(10):986-994.
44. Conforti FL, Spataro R, Sproviero W, et al. Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis. Neurology. 2012;79(24):2315-2320.
45. van Es MA, van Vught PWJ, Blauw HM, et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet. 2008;40(1):29-31.
46. Deng M, Wei L, Zuo X, et al. Genome-wide association analyses in Han Chinese identify two new susceptibility loci for amyotrophic lateral sclerosis. Nat Genet. 2013;45(6):697-700.
47. Alexander MD, Traynor BJ, Miller N, et al. "True" sporadic ALS associated with a novel SOD-1 mutation. Ann Neurol. 2002;52(5):680-683.
48. Chiò A, Calvo A, Moglia C, et al. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case. Neurobiol Aging. 2011;32(3):553.e23-553.e26.
49. Chesi A, Staahl BT, Jovièí A, et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat Neurosci. 2013;16(7):851-855.